Mooren F C, Berthold A, Domschke W, Kreuter J
Department of Medicine B, University of Münster, Germany.
Pharm Res. 1998 Jan;15(1):58-65. doi: 10.1023/a:1011996619500.
The present study was performed to investigate the influence of chitosan microspheres on transport of the hydrophilic, antiinflammatory drug prednisolone sodium phosphate (PSP) across the epithelial barrier.
Microspheres were prepared using a precipitation method and loaded with PSP. Transport studies were performed in a diffusion cell chamber using the polarized human cell line HT-29B6. Porcine small intestine and fluorescence-labeled microspheres were used to investigate penetration ability of microspheres.
It was shown that transport of PSP drug solution was not saturable across the cell monolayers (P = 8.68 +/- 8.24 x 10(-6) cm sec-1) and no sodium dependency could be established. EGTA treatment resulted in an increased permeability (P = 18.69 +/- 1.09 x 10(-6) cm sec-1). After binding of prednisolone to chitosan microspheres its permeability was enhanced drastically compared with the drug solution (P = 35.37 +/- 3.21 x 10(-6) cm sec-1). This effect was prevented by EGTA treatment (P = 15.11 +/- 2.57 x 10(-6) cm sec-1). Furthermore the supporting effect of chitosan microspheres was impaired by pH and ion composition of the medium, whereas the effect remained unchanged in cells treated with bacterial lipopolysaccharides. In vitro incubation of fluorescence-labeled microspheres in the lumen of freshly excised intestine revealed a significant amount of the spheres in the submucosa.
Chitosan microspheres are a useful tool to improve the uptake of hydrophilic substances like PSP across epithelial layers. The effect is dependent on the integrity of the intercellular cell contact zones and the microparticles are able to pass the epithelial layer. Their potential benefit under inflammatory conditions like in inflammatory bowel disease, in order to establish high drug doses at the region of interest, remains to be shown.
进行本研究以调查壳聚糖微球对亲水性抗炎药物泼尼松龙磷酸钠(PSP)跨上皮屏障转运的影响。
采用沉淀法制备微球并负载PSP。使用极化的人细胞系HT - 29B6在扩散池腔室中进行转运研究。用猪小肠和荧光标记的微球来研究微球的渗透能力。
结果表明,PSP药物溶液跨细胞单层的转运不饱和(P = 8.68 ± 8.24×10⁻⁶ cm·sec⁻¹),且未发现钠依赖性。EGTA处理导致通透性增加(P = 18.69 ± 1.09×10⁻⁶ cm·sec⁻¹)。泼尼松龙与壳聚糖微球结合后,其通透性与药物溶液相比大幅提高(P = 35.37 ± 3.21×10⁻⁶ cm·sec⁻¹)。EGTA处理可阻止这种效应(P = 15.11 ± 2.57×10⁻⁶ cm·sec⁻¹)。此外,壳聚糖微球的支持作用受培养基的pH值和离子组成影响,而在用细菌脂多糖处理的细胞中该效应保持不变。在新鲜切除的肠腔中对荧光标记的微球进行体外孵育,结果显示黏膜下层有大量微球。
壳聚糖微球是一种有用的工具,可提高亲水性物质如PSP跨上皮层的摄取。该效应取决于细胞间接触区的完整性,且微粒能够穿过上皮层。它们在炎症性疾病(如炎症性肠病)等炎症条件下,为在感兴趣区域建立高药物剂量的潜在益处仍有待证明。